Platform Device

MicroTransponder is developing a platform technology for wireless neurostimulation. The first product being developed is the SAINT™ (Subcutaneous Arrangement of Implantable Neural Transponders) MicroStim System. The SAINT™ eliminates the need for implantable battery or wires. It is implantable in a simple 30 minute outpatient procedure. This implanted platform technology will be coupled to an external controller, which can be worn like an armband; and will provide the power and stimulus directions for the device. The external controller will also have the ability to be hooked up to a laptop or PDA in order to change the stimulus parameters to better treat the patient's pain profile.

Current Treatments for Chronic Pain

Each year over 40 million Americans suffer from chronic pain. They miss over 500 million days of work, and spend billions on doctor visits and treatment. Current pharmaceutical treatments are costly, ineffective, have negative side effects, and are not effective for large percentages of the patient population. Over $2.5 is spent annually on neurostimulation treatments, but out of the 70,000 annual trial implantations, only 50% of the patients elect to get a permanent implant. Of those 35,000; 50% fail in the first year and 70% by the third year. Only 1 in 7 devices implanted are a long term success. Most of these failures are a result of wire breakage or migration. Our device avoids the side effects that accompany drugs while also eliminating the wires and batteries that break and cause migration.